Henry Schein | HSIC - Current Assets


Henry Schein reported $4.5B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agilent USD 4.76B 148M Mar/2026
Align Technology USD 2.66B 38.87M Mar/2026
Bruker USD 2.1B 108.9M Mar/2026
Cardinal Health USD 38.06B 1.17B Mar/2026
Charles River Laboratories USD 1.49B 41.76M Mar/2026
Cigna USD 43.03B 4.78B Mar/2026
Concord Medical Services Hldg CNY 1.03B 174.49M Jun/2025
Cooper Companies USD 2.3B 166M Mar/2026
CVS Health USD 74.82B 103M Mar/2026
Danaher USD 13.94B 1.18B Mar/2026
Dentsply International USD 1.85B 178M Mar/2026
Encompass Health USD 1.03B 123.2M Mar/2026
Henry Schein USD 4.5B 32M Mar/2026
Idexx Laboratories USD 1.45B 40.25M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
Laboratory Of America USD 4.56B 538.3M Mar/2026
McKesson USD 57.21B 2.49B Mar/2026
Mettler Toledo International USD 1.33B 30.76M Mar/2026
Owens Minor USD 588.5M 40.63M Mar/2026
Quest Diagnostics USD 2.57B 188M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Tenet Healthcare USD 8.36B 507M Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Universal Health Services USD 3.5B 91.79M Mar/2026
Veradigm USD 679.65M 131.12M Dec/2022
Waters USD 3.72B 1.73B Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026
Zoetis USD 6.47B 294M Mar/2026